US diabetes experts are calling for a major overhaul of how hospital patients suffering with high-blood sugar levels are treated.

New recommendations have been issued by the American Association of Clinical Endocrinologists (AACE) and the American Diabetes Association (ADA), which have advised glucose targets of 140-180mg/dL for patients in intensive care units and 100-180mg/dL for patients admitted to general medical-surgical wards.

The revised targets are a result of a failure to manage glucose targets in the US and after results of several randomised controlled clinical trials in critically and non-critically ill patients failed to show a significant improvement in mortality with intensive insulin therapy.